Title: Impacts of Salt Restriction on Nutritional Status, Sarcopenia, and Mortality of Cirrhotic
Patients With Ascites
Version: 3 Date: 05 Feb 2025
Reviewer's report:
Comments to the Authors
1. This study did not elaborate on a salt-restricted diet, such as the specific value of daily salt
intake.
2. Evaluating the effect of ascites management only by the frequency of abdominal paracentesis
without taking into account factors such as the volume and nature of ascites cannot accurately
determine the true impact of salt-restriction on ascites management.
3. The three-month follow-up period may not fully assess the long-term effects of salt-restricted
diets nor determine the long-term efficacy and safety of salt-restricted diets.
4. In the methods section of the abstract, the follow-up time is mentioned as 6 months, whereas
in the subsequent text, the follow-up time is stated as 3 months. Please correct this discrepancy.
5. In this article, when professional term abbreviations first appear, their full forms should be
used. (For example, LVP, SBP, GI, etc.)
6. This study is a prospective design. Please supplement the informed consent form of the
patients.
7. Please conduct a K-M survival analysis in the results of the study.
8. The structure of the results section is disorganized. Please make the necessary revisions.
9. Please explain whether sarcopenia in patients with cirrhotic ascites exists at baseline or
develops during follow-up period.
Title: Impacts of Salt Restriction on Nutritional Status, Sarcopenia, and Mortality of Cirrhotic
Patients With Ascites
Version: 3 Date: 05 Feb 2025
Reviewer's report:
Comments to the Authors
1. This study did not elaborate on a salt-restricted diet, such as the specific value of daily salt
intake.
2. Evaluating the effect of ascites management only by the frequency of abdominal paracentesis
without taking into account factors such as the volume and nature of ascites cannot accurately
determine the true impact of salt-restriction on ascites management.
3. The three-month follow-up period may not fully assess the long-term effects of salt-restricted
diets nor determine the long-term efficacy and safety of salt-restricted diets.
4. In the methods section of the abstract, the follow-up time is mentioned as 6 months, whereas
in the subsequent text, the follow-up time is stated as 3 months. Please correct this discrepancy.
5. In this article, when professional term abbreviations first appear, their full forms should be
used. (For example, LVP, SBP, GI, etc.)
6. This study is a prospective design. Please supplement the informed consent form of the
patients.
7. Please conduct a K-M survival analysis in the results of the study.
8. The structure of the results section is disorganized. Please make the necessary revisions.
9. Please explain whether sarcopenia in patients with cirrhotic ascites exists at baseline or
develops during follow-up period.
Please review this paper.
user
Title: Impacts of Salt Restriction on Nutritional Status, Sarcopenia, and Mortality of Cirrhotic
Patients With Ascites
Version: 3 Date: 05 Feb 2025
Reviewer's report:
Comments to the Authors
1. This study did not elaborate on a salt-restricted diet, such as the specific value of daily salt
intake.
2. Evaluating the effect of ascites management only by the frequency of abdominal paracentesis
without taking into account factors such as the volume and nature of ascites cannot accurately
determine the true impact of salt-restriction on ascites management.
3. The three-month follow-up period may not fully assess the long-term effects of salt-restricted
diets nor determine the long-term efficacy and safety of salt-restricted diets.
4. In the methods section of the abstract, the follow-up time is mentioned as 6 months, whereas
in the subsequent text, the follow-up time is stated as 3 months. Please correct this discrepancy.
5. In this article, when professional term abbreviations first appear, their full forms should be
used. (For example, LVP, SBP, GI, etc.)
6. This study is a prospective design. Please supplement the informed consent form of the
patients.
7. Please conduct a K-M survival analysis in the results of the study.
8. The structure of the results section is disorganized. Please make the necessary revisions.
9. Please explain whether sarcopenia in patients with cirrhotic ascites exists at baseline or
develops during follow-up period.
assistant